Diekmann F et al. |
Conversion to rapamycin in renal allograft recipients with biopsy-proven calcineurin inhibitor-induced nephrotoxicity. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750386
|
Manzanares C et al. |
Influence of hepatitis C virus infection on FK 506 blood levels in renal transplant patients. |
1998 |
Transplant. Proc. |
pmid:9636513
|
van Duijnhoven E et al. |
Tacrolimus dosing requirements in diabetic and nondiabetic patients calculated from pretransplantation data. |
1998 |
Transplant. Proc. |
pmid:9636514
|
Kamińska D et al. |
Significant infections after hand transplantation in a Polish population. |
2014 |
Transplant. Proc. |
pmid:25380943
|
Frei U and Wagner K |
Renal function in liver transplant patients receiving FK506 or cyclosporin A immunosuppressive therapy. |
1994 |
Transplant. Proc. |
pmid:7527963
|
Morris R |
Modes of action of FK506, cyclosporin A, and rapamycin. |
1994 |
Transplant. Proc. |
pmid:7527964
|
Abou-Jaoude MM et al. |
Cyclosporine microemulsion (Neoral) versus tacrolimus (FK506) as maintenance therapy in kidney transplant patients. |
2003 |
Transplant. Proc. |
pmid:14612103
|
Khalaf H et al. |
Tacrolimus (FK 506) given three times daily after liver transplantation for minimizing nephrotoxicity and neurotoxicity. |
2003 |
Transplant. Proc. |
pmid:14612120
|
Park K et al. |
Efficacy of tacrolimus in primary kidney transplant patients: multicenter, open-label prospective study. |
2000 |
Transplant. Proc. |
pmid:11119901
|
Lane BC et al. |
Evaluation of calcineurin's role in the immunosuppressive activity of FK 506, related macrolactams, and cyclosporine. |
1993 |
Transplant. Proc. |
pmid:7679829
|
Aktürk S et al. |
Pregnancy After Kidney Transplantation: Outcomes, Tacrolimus Doses, and Trough Levels. |
2015 |
Transplant. Proc. |
pmid:26093738
|
Celli S et al. |
Long-term survival of heart and liver xenografts with splenectomy and FK 506. |
1993 |
Transplant. Proc. |
pmid:7679830
|
Beysens AJ et al. |
FK 506: monitoring in plasma or in whole blood? |
1991 |
Transplant. Proc. |
pmid:1721263
|
Regazzi MB et al. |
Interaction between FK 506 and diltiazem in an animal model. |
1996 |
Transplant. Proc. |
pmid:8623215
|
Hashikura Y et al. |
Immunosuppressant switching between cyclosporine and tacrolimus after liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8623218
|
Ma A et al. |
Immunological evaluation of combination therapy with tacrolimus and sirolimus on long-term allograft survival in nonhuman primates. |
2005 Jan-Feb |
Transplant. Proc. |
pmid:15808578
|
Rahamimov R et al. |
Rejection rate in living donor kidney transplantation with and without basiliximab in tacrolimus/mycophenolate mofetil-based protocol. |
2003 |
Transplant. Proc. |
pmid:12644082
|
Venkataramanan R et al. |
Pharmacokinetics of FK 506: preclinical and clinical studies. |
1990 |
Transplant. Proc. |
pmid:1689899
|
Sgrosso JL et al. |
Histopathological findings in heart transplant patients under tacrolimus-mycophenolate mofetil versus cyclosporine microemulsion-azathioprine. |
2002 |
Transplant. Proc. |
pmid:11959214
|
Weiler N et al. |
Tacrolimus effects and side effects after liver transplantation: is there a difference between immediate and extended release? |
2013 Jul-Aug |
Transplant. Proc. |
pmid:23953543
|
Qu W et al. |
Correlation Between Immunosuppressive Therapy and CD4(+) T-Cell Intracellular Adenosine Triphosphate Levels in Liver Transplant Recipients. |
|
Transplant. Proc. |
pmid:27569951
|
Rudich SM et al. |
Immunosuppression using tacrolimus, mycophenolate, and prednisone following orthotopic liver transplantation: a single-center experience. |
1998 |
Transplant. Proc. |
pmid:9636574
|
Imamura M et al. |
FK 506 inhibits severe graft-versus-host disease without mediating cytokine balance and/or cytotoxic molecules. |
2000 |
Transplant. Proc. |
pmid:11120238
|
Jang HJ et al. |
Comparison of pancreas transplantation outcome between the cyclosporine and tacrolimus eras. |
2000 |
Transplant. Proc. |
pmid:11120249
|
Forsythe J |
Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. The European Multicentre Tacrolimus/MMF Study Group. |
1999 |
Transplant. Proc. |
pmid:10576049
|
Ullman KS et al. |
Site of action of cyclosporine and FK 506 in the pathways of communication between the T-lymphocyte antigen receptor and the early activation genes. |
1991 |
Transplant. Proc. |
pmid:1721294
|
Squifflet JP et al. |
The Benelux experience with the combination of tacrolimus and mycophenolate mofetil. |
1999 |
Transplant. Proc. |
pmid:10576050
|
Watarai Y et al. |
Effect of tacrolimus and cyclosporine on renal microcirculation and nitric oxide production. |
2004 |
Transplant. Proc. |
pmid:15518773
|
Sigal NH et al. |
Is FKBP involved in the immunosuppressive and/or toxic mechanism of action of FK 506? |
1991 |
Transplant. Proc. |
pmid:1721295
|
Kawaoka T et al. |
Two patients treated with simeprevir plus pegylated-interferon and ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation: case report. |
2015 |
Transplant. Proc. |
pmid:25891736
|
Yang S et al. |
Characteristics of long-term immunosuppressive therapy in Chinese pediatric renal transplant patients: a single-center experience. |
2009 |
Transplant. Proc. |
pmid:20005361
|
Nassar CA et al. |
Effects of long-term FK 506 therapy on the alveolar bone and cementum of rats. |
2009 |
Transplant. Proc. |
pmid:19545747
|
Moscicka M et al. |
The effect of cyclosporine and tacrolimus on indigenous bacterial flora in human skin grafts. |
2003 |
Transplant. Proc. |
pmid:14529942
|
Bahra M et al. |
Repeated steroid pulse therapies in HCV-positive liver recipients: significant risk factor for HCV-related graft loss. |
2005 |
Transplant. Proc. |
pmid:15919436
|
Okamoto M et al. |
Detection of allograft rejection in rat small bowel transplantation by analysing the in situ distribution of S-phase lymphocytes. |
1994 |
Transplant. Proc. |
pmid:7518145
|
Ciancio G et al. |
Pilot Randomized Trial of Tacrolimus/Everolimus vs Tacrolimus/Enteric-Coated Mycophenolate Sodium in Adult, Primary Kidney Transplant Recipients at a Single Center. |
|
Transplant. Proc. |
pmid:27569936
|
González-Pinto IM et al. |
Five-year follow-up of a trial comparing Tacrolimus and cyclosporine microemulsion in liver transplantation. |
2005 |
Transplant. Proc. |
pmid:15919441
|
Ricordi C et al. |
Effect of FK 506 on human pancreatic islets following renal subcapsular transplantation in diabetic nude mice. |
1992 |
Transplant. Proc. |
pmid:1376512
|
Kim HC et al. |
Primary immunosuppression with tacrolimus in renal transplantation: a single center experience. |
2003 |
Transplant. Proc. |
pmid:12591370
|
Barkholt LM et al. |
New criteria for diagnosing cytomegalovirus hepatitis in liver transplant patients. |
1995 |
Transplant. Proc. |
pmid:7533375
|
Cooper MH et al. |
Evaluation of the influence of FK 506, rapamycin, and cyclosporine on processing and presentation of particulate antigen by macrophages: assessment of a drug "carry-over" effect. |
1991 |
Transplant. Proc. |
pmid:1721326
|
Maes BD and Vanrenterghem YF |
Cyclosporine: advantages versus disadvantages vis-Ã -vis tacrolimus. |
2004 |
Transplant. Proc. |
pmid:15041305
|
Hesselink DA et al. |
The use of cyclosporine in renal transplantation. |
2004 |
Transplant. Proc. |
pmid:15041316
|
Chen JW et al. |
Ten-year results of a randomised prospective study of FK506 versus cyclosporine in management of primary orthotopic liver transplantation. |
2002 |
Transplant. Proc. |
pmid:12176460
|
Figueras J et al. |
Steroid-free regimen with daclizumab, mycophenolate mofetil, and tacrolimus in liver transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176461
|
Costa A et al. |
Small bowel myoelectrical activity after transplantation in pigs: motility versus ACR score. |
1997 |
Transplant. Proc. |
pmid:9142281
|
Soin AS et al. |
Complement activation during rejection in experimental intestinal transplantation. |
1997 |
Transplant. Proc. |
pmid:9142282
|
Chmiel B et al. |
Rheological properties of red blood cells in kidney transplant recipients: the role of lipid profile and type of immunosuppresion. |
2005 |
Transplant. Proc. |
pmid:15919493
|
Sakamoto K et al. |
Sodium-losing nephropathy and distal tubular damage of transplant kidneys with FK506 administration. |
1995 |
Transplant. Proc. |
pmid:7533434
|
Ochiai T et al. |
Phase III study of FK 506 in kidney transplantation. Japanese FK 506 Study Group. |
1995 |
Transplant. Proc. |
pmid:7533435
|
Armitage JM et al. |
The clinical trial of FK 506 as primary and rescue immunosuppression in adult cardiac transplantation. |
1991 |
Transplant. Proc. |
pmid:1721358
|
Armitage JM et al. |
The clinical trial of FK 506 as primary and rescue immunosuppression in pediatric cardiac transplantation. |
1991 |
Transplant. Proc. |
pmid:1721359
|
Strassburg A et al. |
Basiliximab reduces acute liver allograft rejection in pediatric patients. |
2002 |
Transplant. Proc. |
pmid:12270443
|
Gojowy D et al. |
High Frequency of Arterial Hypertension in Patients After Liver Transplantation. |
2016 |
Transplant. Proc. |
pmid:27496479
|
Yoshimura N et al. |
Safety analysis following tacrolimus immunosuppression in renal transplant recipients in Japan: 3-year results in over 1000 patients. |
2002 |
Transplant. Proc. |
pmid:12176501
|
Kilinç M et al. |
FK 506-induced fulminant leukoencephalopathy after kidney transplantation: case report. |
2002 |
Transplant. Proc. |
pmid:12072309
|
Hung CM et al. |
Tacrolimus to rescue refractory hepatic allograft rejection: a collaborative study in Taiwan. |
1998 |
Transplant. Proc. |
pmid:9838572
|
Miller J |
Tacrolimus and mycophenolate mofetil in renal transplant recipients: one year results of a multicenter, randomized dose ranging trial. FK506/MMF Dose-Ranging Kidney Transplant Study Group. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083106
|
Mieles L et al. |
Glycemia and insulin need following FK 506 rescue therapy in liver transplant recipients. |
1991 |
Transplant. Proc. |
pmid:1703362
|
Busuttil RW and Holt CD |
Tacrolimus (FK506) is superior to cyclosporine in liver transplantation. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123119
|
Namieno T and Uchino J |
Comparative study of the effects of cyclosporine and FK 506 on rat hepatocytes cocultured with nonparenchymal liver cells. |
1996 |
Transplant. Proc. |
pmid:8908147
|
Tze WJ et al. |
Effect of FK 506 on glucose metabolism and insulin secretion in normal rats. |
1991 |
Transplant. Proc. |
pmid:1721391
|
Bilbao I et al. |
Comparison between tacrolimus and neoral cyclosporine administered by oral route in liver transplantation. |
2001 |
Transplant. Proc. |
pmid:11377472
|
van Duijnhoven EM et al. |
Evidence that fasting does not significantly affect trough levels of tacrolimus in stable renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176552
|
Braun F et al. |
Pharmacokinetics of tacrolimus primary immunosuppression in kidney transplant recipients. |
2001 |
Transplant. Proc. |
pmid:11377473
|
Saito K et al. |
Study of pharmacokinetic parameters of tacrolimus by different oral administration periods in renal transplantation. |
2002 |
Transplant. Proc. |
pmid:12176553
|
Gu B et al. |
Exploration of Fecal Microbiota Transplantation in the Treatment of Refractory Diarrhea After Renal Transplantation. |
2018 |
Transplant. Proc. |
pmid:29880353
|
Wierzbicka A et al. |
Lipid, carbohydrate metabolism, and antioxidant status in children after liver transplantation. |
2007 |
Transplant. Proc. |
pmid:17580179
|
Weinbroum AA et al. |
Lack of cumulative effect of tacrolimus and low flow on a rat isolated liver. |
2001 |
Transplant. Proc. |
pmid:11543812
|
Zuckermann A et al. |
Benefit of mycophenolate mofetil in patients with cyclosporine A-induced nephropathy after lung transplantation. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083518
|
Zanker B et al. |
Comparison of MPA trough levels in patients with severe diabetes mellitus and from non-diabetics after transplantation. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083521
|
Beck Y and Akiyama N |
Effect of FK-506 and cyclosporine on human lymphocyte responses in vitro. |
1989 |
Transplant. Proc. |
pmid:2472695
|
Ohdan H et al. |
Prolongation of hamster-to-rat liver xenograft survival by donor bone marrow augmentation. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123589
|
Yamagami S et al. |
Rejection mechanism and immunosuppression by FK 506 and anti-leukocyte function associated antigen-1 antibody in concordant corneal xenotransplantation. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123598
|
Mabuchi M et al. |
Insulin-like growth factor-I enhances choleretic action of FK506 in rats. |
2003 |
Transplant. Proc. |
pmid:12826230
|
McLaughlin GE et al. |
Use of phenobarbital in the management of acute tacrolimus toxicity: a case report. |
2000 |
Transplant. Proc. |
pmid:10812158
|
Yoshimi F et al. |
Canine total orthotopic small bowel transplantation under FK 506. |
1991 |
Transplant. Proc. |
pmid:1721422
|
Kawauchi M et al. |
Which are the target vessels of xeno- and allo-lung rejection?--a primate single lung transplantation study. |
1996 |
Transplant. Proc. |
pmid:8658719
|
Lo A et al. |
Observations on the use of sirolimus and tacrolimus in high-risk renal transplant recipients. |
2003 |
Transplant. Proc. |
pmid:12742477
|
El-Sabrout R et al. |
Rejection-free protocol using sirolimus-tacrolimus combination for pediatric renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176636
|
Ishikawa S et al. |
Management of Juvenile Idiopathic Arthritis in ABO-incompatible Kidney Transplantation: A Case Report. |
2018 |
Transplant. Proc. |
pmid:29661455
|
Wu M et al. |
Cyclosporine and tacrolimus alter renin-angiotesin system in mouse medullary-thick ascending limb cultured cells. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267198
|
Ueno T et al. |
Conversion to prolonged-release tacrolimus for pediatric living related donor liver transplant recipients. |
2013 |
Transplant. Proc. |
pmid:23769087
|
Halloran PF et al. |
Calcineurin and the biological effect of cyclosporine and tacrolimus. |
1998 |
Transplant. Proc. |
pmid:9723430
|
Walgenbach KJ et al. |
Upregulation of basic fibroblast growth factor during chronic rejection of rat intestinal allografts and its downregulation by FK 506. |
1998 |
Transplant. Proc. |
pmid:9745501
|
Nalesnik MA et al. |
Toxicology of FK-506 in the Lewis rat. |
1987 |
Transplant. Proc. |
pmid:2445084
|
Aktas S et al. |
Comparison of basiliximab and daclizumab with triple immunosuppression in renal transplantation. |
2011 |
Transplant. Proc. |
pmid:21440732
|
Murio JE et al. |
Compassionate use of FK 506 in liver transplantation. |
1995 |
Transplant. Proc. |
pmid:7544501
|
Takahara S et al. |
Clinical evaluation of trough levels and area under the curve in cyclosporine- and FK 506-treated kidney transplant recipients. |
1994 |
Transplant. Proc. |
pmid:7524219
|
Llull R et al. |
Multilineage amplification of graft-vs-host disease-resistant chimerism following rat vascularized bone marrow allotransplantation. |
1995 |
Transplant. Proc. |
pmid:7544504
|
Velioglu A et al. |
Association of BK Virus Titers With Lymphocyte Count in Renal Transplant Patients. |
2015 |
Transplant. Proc. |
pmid:26093733
|
Sainsbury TS et al. |
Differential effects of FK 506 and cyclosporine on hair regrowth in the DEBR model of alopecia areata. |
1991 |
Transplant. Proc. |
pmid:1721453
|
Kocak H et al. |
Tacrolimus plus low-dose mycophenolate mofetil in renal transplant recipients: better 2-year graft and patient survival than with a higher mycophenolate mofetil dose. |
2005 |
Transplant. Proc. |
pmid:16213288
|
Fujino Y et al. |
FK 506 treatment of experimental autoimmune uveoretinitis in primates. |
1991 |
Transplant. Proc. |
pmid:1721454
|
Lo A et al. |
Outcome of simultaneous kidney-pancreas transplantation in African-American recipients: a case control study. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267465
|
Miki T et al. |
Tacrolimus enhances the immunosuppressive effect of cyclophosphamide but not that of leflunomide or mycophenolate mofetil in a model of discordant liver xenotransplantation. |
1998 |
Transplant. Proc. |
pmid:9636444
|
Mehra MR et al. |
Corticosteroid weaning in the tacrolimus and mycophenolate era in heart transplantation: clinical and neurohormonal benefits. |
2004 |
Transplant. Proc. |
pmid:15686716
|
Miyagawa S et al. |
Mechanism of unresponsiveness in rats induced by a short course of FK 506 or CyA. |
1991 |
Transplant. Proc. |
pmid:1703687
|
Anglicheau D et al. |
Pharmacogenetics of tacrolimus and sirolimus in renal transplant patients: from retrospective analyses to prospective studies. |
2007 |
Transplant. Proc. |
pmid:17889118
|
Pridöhl O et al. |
Low-dose immunosuppression with FK 506 and sirolimus after liver transplantation: 1-year results. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750384
|